Citations for
1F2R, KLK6
KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease.
Billi AC, Ludwig JE, Fritz Y, Rozic R, Swindell WR, Tsoi LC, Gruszka D, Abdollahi-Roodsaz S, Xing X, Diaconu D, Uppala R, Camhi MI, Klenotic PA, Sarkar MK, Husni ME, Scher JU, McDonald C, Kahlenberg JM, Midura RJ, Gudjonsson JE, Ward NL.
J Clin Invest Clin Invest. 2020 Mar 10. pii: 133159. doi: 10.1172/JCI133159. [Epub ahead of print] 2020
2KLK10, KLK6
Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer's disease and associated with CSF-TAU and FDG-PET.
Goldhardt O, Warnhoff I, Yakushev I, Begcevic I, Förstl H, Magdolen V, Soosaipillai A, Diamandis E, Alexopoulos P, Grimmer T.
Transl Neurodegener 8:25. doi: 10.1186/s40035-019-0168-6. eCollection 2019. 2019
3KLK6
Kallikrein 6 protease advances colon tumorigenesis via induction of the high mobility group A2 protein.
Chen H, Sells E, Pandey R, Abril ER, Hsu CH, Krouse RS, Nagle RB, Pampalakis G, Sotiropoulou G, Ignatenko NA.
Oncotarget 10(58):6062-6078. doi: 10.18632/oncotarget.27153. eCollection 2019 Oct 22. 2019
4KLK6
A proinflammatory role of KLK6 protease in Netherton syndrome.
Zingkou E, Pampalakis G, Charla E, Nauroy P, Kiritsi D, Sotiropoulou G.
J Dermatol Sci 95(1):28-35. doi: 10.1016/j.jdermsci.2019.06.004. Epub 2019 Jun 16. 2019
5KLK6
Biochemical pathways mediated by KLK6 protease in breast cancer.
Pampalakis G, Zingkou E, Sidiropoulos KG, Diamandis EP, Zoumpourlis V, Yousef GM, Sotiropoulou G.
Mol Oncol 13(11):2329-2343. doi: 10.1002/1878-0261.12493. Epub 2019 Sep 30. 2019
6KLK10, KLK15, KLK2, KLK3, KLK6, KLK7, KLK8
Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Tailor PD, Kodeboyina SK, Bai S, Patel N, Sharma S, Ratnani A, Copland JA, She JX, Sharma A.
Oncotarget 9(25):17876-17888. doi: 10.18632/oncotarget.24947. eCollection 2018 Apr 3. 2018
7KLK6
KLK6 Promotes Growth, Migration, and Invasion of Gastric Cancer Cells.
Zhu S, Shi J, Zhang S, Li Z.
J Gastric Cancer 18(4):356-367. doi: 10.5230/jgc.2018.18.e35. Epub 2018 Nov 14. 2018
8KLK6
KLK6 protease accelerates skin tumor formation and progression.
Khoury N, Zingkou E, Pampalakis G, Sofopoulos M, Zoumpourlis V, Sotiropoulou G.
Carcinogenesis 39(12):1529-1536. doi: 10.1093/carcin/bgy110. 2018
9KLK6
Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms.
Yoon H, Radulovic M, Scarisbrick IA.
Biol Chem 399(9):1041-1052. doi: 10.1515/hsz-2018-0122. 2018
10KLK1, KLK10, KLK13, KLK14, KLK6
Functional interrelationships between the kallikrein-related peptidases family and the classical kinin system in the human neutrophil.
Ehrenfeld P, Bhoola KD, Matus CE, Figueroa CD.
Biol Chem 399(9):925-935. doi: 10.1515/hsz-2017-0338. Review. 2018
11KLK5, KLK6, KLK7, KLK8, KLK9
Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 - KLK9), using Next-generation sequencing.
Adamopoulos PG, Kontos CK, Scorilas A.
Sci Rep 7(1):17299. doi: 10.1038/s41598-017-16269-6. 2017
12KLK6
Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
Briollais L, Ozcelik H, Xu J, Kwiatkowski M, Lalonde E, Sendorek DH, Fleshner NE, Recker F, Kuk C, Olkhov-Mitsel E, Savas S, Hanna S, Juvet T, Hunter GA, Friedlander M, Li H, Chadwick K, Prassas I, Soosaipillai A, Randazzo M, Trachtenberg J, Toi A, Shiah YJ, Fraser M, van der Kwast T, Bristow RG, Bapat B, Diamandis EP, Boutros PC, Zlotta AR.
J Natl Cancer Inst 109(4). doi: 10.1093/jnci/djw258. 2017
13KLK6
Activity of human kallikrein-related peptidase 6 (KLK6) on substrates containing sequences of basic amino acids. Is it a processing protease?
Silva RN, Oliveira LCG, Parise CB, Oliveira JR, Severino B, Corvino A, di Vaio P, Temussi PA, Caliendo G, Santagada V, Juliano L, Juliano MA.
Biochim Biophys Acta Proteins Proteom 1865(5):558-564. doi: 10.1016/j.bbapap.2017.02.017. Epub 2017 Feb 28. 2017
14KLK6, KLK7, KLK9
Prognostic significance of multiple kallikreins in high-grade astrocytoma.
Drucker KL, Gianinni C, Decker PA, Diamandis EP, Scarisbrick IA.
BMC Cancer 15:565. doi: 10.1186/s12885-015-1566-5. 2015
15KLK10, KLK6
Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Grin A, Samaan S, Tripathi M, Rotondo F, Kovacs K, Bassily MN, Yousef GM.
Hum Pathol 46(4):541-8. doi: 10.1016/j.humpath.2014.12.005. Epub 2014 Dec 31. 2015
16KLK6
Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH, Kolb M, Zaoui K, Flechtenmacher C, Grabe N, Weber KJ, Hielscher T, Plinkert PK, Hess J.
Mol Cancer 14:107. doi: 10.1186/s12943-015-0381-6. 2015
17KLK10, KLK6
Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
Kolin DL, Sy K, Rotondo F, Bassily MN, Kovacs K, Brezden-Masley C, Streutker CJ, Yousef GM.
Biol Chem 395(9):1087-93. doi: 10.1515/hsz-2014-0143. 2014
18BDRKB1, KLK1, KLK11, kLK6
Bioregulation of kallikrein-related peptidases 6, 10 and 11 by the kinin B₁ receptor in breast cancer cells.
Ehrenfeld P, Manso L, Pavicic MF, Matus CE, Borquez C, Lizama A, Sarmiento J, Poblete MT, Bhoola KD, Naran A, Figueroa CD.
Anticancer Res 34(12):6925-38. 2014
19KLK6
Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
Kolin DL, Sy K, Rotondo F, Bassily MN, Kovacs K, Brezden-Masley C, Streutker CJ, Yousef GM.
Biol Chem 395(9):1087-93. doi: 10.1515/hsz-2014-0143. 2014
20F2R, F2RL1, KLK6
Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.
Yoon H, Radulovic M, Wu J, Blaber SI, Blaber M, Fehlings MG, Scarisbrick IA.
J Neurochem 127(2):283-98. doi: 10.1111/jnc.12293. Epub 2013 May 27. 2013
21KLK6
In vivo analysis of kallikrein-related peptidase 6 (KLK6) function in oligodendrocyte development and the expression of myelin proteins.
Murakami K, Jiang YP, Tanaka T, Bando Y, Mitrovic B, Yoshida S.
Neuroscience 236:1-11. doi: 10.1016/j.neuroscience.2012.12.073. Epub 2013 Jan 31. 2013
22KLK6
Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage.
Martínez-Morillo E, Diamandis A, Romaschin AD, Diamandis EP.
PLoS One 7(9):e45676. doi: 10.1371/journal.pone.0045676. Epub 2012 Sep 25. 2012
23KLK6
Kallikrein 6 is a novel molecular trigger of reactive astrogliosis.
Scarisbrick IA, Radulovic M, Burda JE, Larson N, Blaber SI, Giannini C, Blaber M, Vandell AG.
Biol Chem 393(5):355-67. doi: 10.1515/hsz-2011-0241. 2012
24KLK6
Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors.
Talieri M, Zoma M, Devetzi M, Scorilas A, Ardavanis A.
Tumour Biol 33(5):1375-83. doi: 10.1007/s13277-012-0385-4. Epub 2012 Apr 3. 2012
25KLK6
Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis.
Scarisbrick IA, Yoon H, Panos M, Larson N, Blaber SI, Blaber M, Rodriguez M.
Brain Pathol 22(5):709-22. doi: 10.1111/j.1750-3639.2012.00577.x. Epub 2012 Mar 21. 2012
26KLK6, KLK8
Kallikrein-related peptidase 8-dependent skin wound healing is associated with upregulation of kallikrein-related peptidase 6 and PAR2.
Kishibe M, Bando Y, Tanaka T, Ishida-Yamamoto A, Iizuka H, Yoshida S.
J Invest Dermatol 132(6):1717-24. doi: 10.1038/jid.2012.18. Epub 2012 Feb 23. 2012
27KLK10, KLK6
The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Koh SC, Razvi K, Chan YH, Narasimhan K, Ilancheran A, Low JJ, Choolani M; Ovarian Cancer Research Consortium of SE Asia.
Arch Gynecol Obstet 284(1):183-90. doi: 10.1007/s00404-010-1605-z. Epub 2010 Aug 1. 2011
28KLK1, KLK15, KLK6, KLK7
Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.
Gabril M, White NM, Moussa M, Chow TF, Metias SM, Fatoohi E, Yousef GM.
Biol Chem iol Chem. 2010 Feb 3. [Epub ahead of print]PMID: 20128686 2010
29KLK13, KLK6
KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
White NM, Mathews M, Yousef GM, Prizada A, Popadiuk C, Doré JJ.
Br J Cancer 101(7):1107-13.PMID: 19707197 2009
30KLK6
High Kallikrein-Related Peptidase 6 in Non-Small Cell Lung Cancer Cells: an indicator of tumor proliferation and poor prognosis.
Nathalie HV, Chris P, Serge G, Catherine C, Benjamin B, Claire B, Christelle P, Briollais L, Pascale R, Marie-Lise J, Yves C.
J Cell Mol Med Cell Mol Med. 2009 May 1. [Epub ahead of print]PMID: 19426157 2009
31KLK1, KLK13, KLK14, KLK2, KLK5, KLK6
Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility.
Emami N, Scorilas A, Soosaipillai A, Earle T, Mullen B, Diamandis EP.
Biol Chem 390(9):921-9.PMID: 19558318 2009
32KLK6, KRAS
Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells.
Henkhaus RS, Gerner EW, Ignatenko NA.
Biol Chem 389(6):757-64.PMID: 18627290 2008
33KLK4, KLK5, KLK6, KLK7
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.
Debela M, Beaufort N, Magdolen V, Schechter NM, Craik CS, Schmitt M, Bode W, Goettig P.
Biol Chem 389(6):623-32. Review.PMID: 18627343 2008
34KLK1, KLK5, KLK6, KLK13, KLK14
A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation.
Borgono CA, Michael IP, Komatsu N, Jayakumar A, Kapadia R, Clayman GL, Sotiropoulou G, Diamandis EP.
J Biol Chem 282(6):3640-52. Epub 2006 Dec 11. 2007
35KLK5, KLK6, KLK8, KLK9
Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells.
Shinoda Y, Kozaki K, Imoto I, Obara W, Tsuda H, Mizutani Y, Shuin T, Fujioka T, Miki T, Inazawa J.
Cancer Sci 98(7):1078-86. Epub 2007 Apr 24.PMID: 17459052 2007
36KLK13, KLK2, KLK3, KLK5, KLK6, KLK7, KLK8
Distribution of 15 human kallikreins in tissues and biological fluids.
Shaw JL, Diamandis EP.
Clin Chem 53(8):1423-32. Epub 2007 Jun 15.PMID: 17573418 2007
37KLK6
Cloning and characterization of novel isoforms of the human kallikrein 6 gene.
Pampalakis G, Kurlender L, Diamandis EP, Sotiropoulou G.
Biochem Biophys Res Commun 320(1):54-61. 2004
38KLK6
Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells.
Ghosh MC, Grass L, Soosaipillai A, Sotiropoulou G, Diamandis EP.
Tumour Biol 25(4):193-9. 2004
39KLK6
Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors.
Magklara A, Mellati AA, Wasney GA, Little SP, Sotiropoulou G, Becker GW, Diamandis EP.
Biochem Biophys Res Commun 307(4):948-55. 2003
40KLK6
The structure of human prokallikrein 6 reveals a novel activation mechanism for the kallikrein family.
Gomis-Ruth FX, Bayes A, Sotiropoulou G, Pampalakis G, Tsetsenis T, Villegas V, Aviles FX, Coll M.
J Biol Chem 277(30):27273-81. Epub 2002 May 16. 2002
41KLK10, KLK11, KLK12, KLK13, KLK14, KLK4, KLK5, KLK6, KLK7, KLK8, KLK9
The New Human Kallikrein Gene Family: Implications in Carcinogenesis.
Diamandis EP, Yousef GM, Luo I, Magklara I, Obiezu CV.
Trends Endocrinol Metab 11(2):54-60. 2000
42KLK12, KLK13, KLK14, KLK6
Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues.
Yousef GM, Chang A, Diamandis EP.
J Biol Chem 275(16):11891-8. 2000
43KLK6
Human kallikrein 6 as a biomarker of alzheimer's disease.
Diamandis EP, Yousef GM, Petraki C, Soosaipillai AR.
Clin Biochem 33(8):663-7. 2000
44KLK1, KLK10, KLK11, KLK12, KLK13, KLK2, KLK3, KLK4, KLK5, KLK6, KLK7, KLK8, KLK9
Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4.
Harvey TJ, Hooper JD, Myers SA, Stephenson SA, Ashworth LK, Clements JA.
J Biol Chem 275(48):37397-406. 2000
45KLK6
Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease.
Yousef GM, Luo LY, Scherer SW, Sotiropoulou G, Diamandis EP.
Genomics 62(2):251-9 1999
46KLK6
Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain.
Yamashiro K, et al.
Biochim Biophys Acta 1350 : 11-14. 1997
47KLK6
A novel protease homolog differentially expressed in breast and ovarian cancer.
Anisowicz A, et al.
Mol Med 2 : 624-636 1996